Chargement en cours...

Psychopharmacology Today: Where are We and Where Do We Go From Here?

Since the 1950s we have had the same three neurotransmitters to work with to treat depression, one transmitter for psychoses, three for anxiety. We have developed newer drugs that are more tolerable, but we have not developed drugs that are better in efficacy. The last 50-60 years should be consider...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Schwartz, Thomas L.
Format: Artigo
Langue:Inglês
Publié: Medknow Publications 2010
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3031936/
https://ncbi.nlm.nih.gov/pubmed/21327167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0973-1229.58816
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!